CONCORD BIOTECH
Back to All Ratios
|
CONCORD BIOTECH Last 5 Year Asset Turnover History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|
Asset Turnover(x) | 0.56 | 0.52 | 0.53 | 0.50 |
What is the latest Asset Turnover ratio of CONCORD BIOTECH ?
Year | Asset Turnover |
---|---|
Mar2023 | 0.56 |
Mar2022 | 0.52 |
Mar2021 | 0.53 |
Mar2020 | 0.50 |
How is Asset Turnover of CONCORD BIOTECH Trending?
Years | Asset Turnover | % Change | |
---|---|---|---|
Mar2023 | 0.56 | 7.69 | |
Mar2022 | 0.52 | -1.89 | |
Mar2021 | 0.53 | 6.00 | |
Mar2020 | 0.5 | - |
Other Financial Ratios of CONCORD BIOTECH
Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Asset Turnover ratio of peers of CONCORD BIOTECH
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
CONCORD BIOTECH | ₹15,636.1 Cr | -0.4% | -5.3% | NA | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹367,290.0 Cr | -0.9% | 0.9% | 62.6% | Stock Analytics | |
CIPLA | ₹113,357.0 Cr | 3.5% | 4.2% | 51.8% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹111,134.0 Cr | 12.2% | 18% | 103.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹104,235.0 Cr | 0.8% | 5.6% | 19.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹97,001.5 Cr | -1% | -2.4% | 28.4% | Stock Analytics |
CONCORD BIOTECH Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
CONCORD BIOTECH | -0.4% |
-5.3% |
|
SENSEX | 1.7% |
1.5% |
18.7% |
You may also like the below Video Courses